83_FR_14937 83 FR 14870 - The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Letters of Intent for Inaugural Investigator Award Program

83 FR 14870 - The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Letters of Intent for Inaugural Investigator Award Program

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 67 (April 6, 2018)

Page Range14870-14871
FR Document2018-07066

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) is requesting letters of intent for an inaugural Investigator Award Program. The NIH Sexual and Gender Minority (SGM) Investigator Award Program was developed to recognize early-stage investigators who have made substantial, outstanding research contributions in areas related to SGM health and who are poised to become future leaders or are already leading the field of SGM health research. The NIH SGMRO is currently soliciting nominations for the 2018 NIH SGM Investigator Awards.

Federal Register, Volume 83 Issue 67 (Friday, April 6, 2018) 
[Federal Register Volume 83, Number 67 (Friday, April 6, 2018)]
[Notices]
[Pages 14870-14871]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07066]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The National Institutes of Health (NIH) Sexual & Gender Minority 
Research Office Request for Letters of Intent for Inaugural 
Investigator Award Program

AGENCY: National Institutes of Health, HHS.

ACTION: Notice; call for Letters of Intent.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) Sexual & Gender 
Minority Research Office (SGMRO) is requesting letters of intent for an 
inaugural Investigator Award Program. The NIH Sexual and Gender 
Minority (SGM) Investigator Award Program was developed to recognize 
early-stage investigators who have made substantial, outstanding 
research contributions in areas related to SGM health and who are 
poised to become future leaders or are already leading the field of SGM 
health research. The NIH SGMRO is currently soliciting nominations for 
the 2018 NIH SGM Investigator Awards.

DATES: Notices of intent to apply due April 20, 2018 and final 
nominations due May 18, 2018.

FOR FURTHER INFORMATION CONTACT: Karen Parker, Ph.D., Director, Sexual 
& Gender Minority Research Office (SGMRO), 1 Center Drive, Building 1, 
Room 257, Bethesda, MD 20892, [email protected], 301-451-2055.

SUPPLEMENTARY INFORMATION: ``Sexual and gender minority'' is an 
umbrella term that encompasses lesbian, gay, bisexual, and transgender 
populations as well as those whose sexual orientation, gender identity 
and expressions, or reproductive development varies from traditional, 
societal, cultural, or physiological norms.
    The Sexual and Gender Minority Research Office (SGMRO) coordinates 
sexual and gender minority (SGM)-related research and activities by 
working directly with the NIH Institutes, Centers, and Offices. The 
Office was officially established in September 2015 within the NIH 
Division of Program Coordination, Planning, and Strategic Initiatives 
(DPCPSI).
    The SGMRO has the following research-related goals: (1) Expand the 
knowledge base of SGM health and well-being through NIH-supported 
research; (2) Remove barriers to planning, conducting, and reporting 
NIH-supported research about SGM health and well-being; (3) Strengthen 
the community of researchers and scholars who conduct research relevant 
to SGM health and well-being; and (4) Evaluate progress on advancing 
SGM research.

2018 Award Details

    Two non-monetary awards of recognition will be offered to early 
stage investigators who demonstrate both contemporary achievement in 
and a commitment to an area of SGM-related health research. The award 
winners will be invited, with all travel expenses covered (limited to 
reimbursement based on Federal Travel Regulations and HHS and NIH 
guidance), to give a lecture at the NIH on September 6, 2018. This 
event will be webcast live and the presentations will be archived and 
available for future viewing.

Eligibility Criteria

    The following individuals are not eligible to be nominated: Federal 
employees and interns; federal contractors; and members of the NIH SGM 
Research Working Group.
     At the time of the nomination due date, May 11, the 
candidate must meet the NIH's definitions of an early stage 
investigator (ESI) (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-101.html).

Letters of Intent

    A Letter of Intent (LOI) to submit a nomination is required 
(nominees may self-nominate and submit their own LOIs). The LOI should 
be a 1-page, single-spaced Word or PDF document and include:
    1. Nominee's name, title, affiliation, and date of terminal degree.
    2. eRA Commons ID.
    a. Before submitting the LOI, researchers should confirm ESI status 
is correctly marked in their eRA Commons (https://era.nih.gov/) 
profile. If the status is incorrect, please contact the NIH eRA Service 
Desk (https://grants.nih.gov/support/index.html) to resolve the issue 
before submitting an LOI.
    3. SGM research focus of nominee's work.
    Attach the LOI (as a Word or PDF document) to an email and send it 
to [email protected] with the subject line ``2018 SGM 
Investigator

[[Page 14871]]

Award Letter of Intent'' no later than 11:59 p.m. on April 20, 2018.

Nominations

    Nomination packages may be submitted by the nominee or a nominee's 
mentor or colleague. Nomination packages must be a single PDF file that 
includes:
    1. NIH Biosketch including a link (URL) to the nominee's My 
Bibliography in PubMed.
    a. If you do not have a My Bibliography in PubMed, refer to these 
simple step-by-step instructions to save your citations in PubMed to a 
``My Bibliography.''
    b. Use the URL that PubMed automatically generates when you change 
your ``My Bibliography'' sharing setting to public.
    2. Letter of nomination (1,000 words or less) from a mentor or 
colleague familiar with the nominee's work, addressing the nominee's 
innovative contribution to the field of SGM health research, 
crosscutting and collaborative nature of that research, trajectory of 
career development, and leadership strengths. The strongest letters 
will demonstrate the lasting significance and impact of the nominee's 
work to date.
    3. Two letters of endorsement from other mentors or colleagues. 
Letters of endorsement may be less encompassing than the letter of 
nomination, but should address similar themes.
    4. A PDF of a key, peer-reviewed article published in the past 24-
month period, which is first-authored by the nominee. If in press, 
please provide the accepted paper and the letter of acceptance from the 
journal.
    After compiling all the above elements into a single PDF file, 
attach the PDF to an email, and send it to [email protected] 
with the subject line header ``2018 SGM Investigator Award Nomination'' 
no later than 11:59 p.m. on May 18, 2018.

Review and Selection Process

     Stage 1: The SGMRO will assemble a review panel composed 
of NIH staff with relevant expertise. This panel will provide 
recommendations to the SGMRO Director and the DPCPSI Director on 
awardees.
     Stage 2: The SGMRO and DPCPSI Directors will review the 
recommendations and select the final awardees.

    Dated: March 8, 2018.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2018-07066 Filed 4-5-18; 8:45 am]
 BILLING CODE 4140-01-P

14870 Federal Register / Vol. 83, No. 67 / Friday, April 6, 2018 / Notices Branch, Division of Extramural Activities, Dated: April 3, 2018. The SGMRO has the following National Cancer Institute, NIH, 9609 Medical Melanie J. Pantoja, research-related goals: (1) Expand the Center Drive, Room 7W602, Bethesda, MD Program Analyst, Office of Federal Advisory knowledge base of SGM health and 20892–9750, 240–276–6456, tangd@ Committee Policy. well-being through NIH-supported mail.nih.gov. [FR Doc. 2018–07058 Filed 4–5–18; 8:45 am] research; (2) Remove barriers to Name of Committee: National Cancer BILLING CODE 4140–01–P planning, conducting, and reporting Institute Special Emphasis Panel; Cancer NIH-supported research about SGM Epidemiology Cohorts—Infrastructure and health and well-being; (3) Strengthen Research. DEPARTMENT OF HEALTH AND the community of researchers and Date: June 6, 2018. HUMAN SERVICES scholars who conduct research relevant Time: 12:00 p.m. to 3:00 p.m. to SGM health and well-being; and (4) Agenda: To review and evaluate grant National Institutes of Health Evaluate progress on advancing SGM applications. research. Place: National Cancer Institute, Shady The National Institutes of Health (NIH) Grove, 9609 Medical Center Drive, Room Sexual & Gender Minority Research 2018 Award Details 7W612, Rockville, MD 20850 (Telephone Office Request for Letters of Intent for Two non-monetary awards of Conference Call). Inaugural Investigator Award Program recognition will be offered to early stage Contact Person: Shari W. Campbell, DPM, investigators who demonstrate both Scientific Review Officer, Research Programs AGENCY: National Institutes of Health, HHS. contemporary achievement in and a Review Branch, Division of Extramural ACTION: Notice; call for Letters of Intent. commitment to an area of SGM-related Activities, National Cancer Institute, NIH, health research. The award winners will 9609 Medical Center Drive, Room 7W612, SUMMARY: The National Institutes of be invited, with all travel expenses Bethesda, MD 20892–9750, 240–276–7381, Health (NIH) Sexual & Gender Minority covered (limited to reimbursement shari.campbell@nih.gov. Research Office (SGMRO) is requesting based on Federal Travel Regulations and Name of Committee: National Cancer letters of intent for an inaugural HHS and NIH guidance), to give a Institute Special Emphasis Panel; SEP–8A: Investigator Award Program. The NIH lecture at the NIH on September 6, 2018. NCI Clinical and Translational R21. Sexual and Gender Minority (SGM) This event will be webcast live and the Date: June 12, 2018. Investigator Award Program was presentations will be archived and Time: 10:00 a.m. to 5:00 p.m. developed to recognize early-stage available for future viewing. Agenda: To review and evaluate grant applications. investigators who have made Eligibility Criteria Place: National Cancer Institute, Shady substantial, outstanding research Grove, 9609 Medical Center Drive, Room contributions in areas related to SGM The following individuals are not 7W238, Rockville, MD 20850 (Telephone health and who are poised to become eligible to be nominated: Federal Conference Call). future leaders or are already leading the employees and interns; federal Contact Person: Jeffrey E. DeClue, Ph.D., field of SGM health research. The NIH contractors; and members of the NIH Scientific Review Officer, Research Programs SGMRO is currently soliciting SGM Research Working Group. Review Branch, Division of Extramural nominations for the 2018 NIH SGM • At the time of the nomination due Activities, National Cancer Institute, NIH, Investigator Awards. date, May 11, the candidate must meet 9609 Medical Center Drive, Room 7W238, DATES: Notices of intent to apply due the NIH’s definitions of an early stage Bethesda, MD 20892–9750, 240–276–6371, April 20, 2018 and final nominations investigator (ESI) (https:// decluej@mail.nih.gov. due May 18, 2018. grants.nih.gov/grants/guide/notice-files/ Name of Committee: National Cancer FOR FURTHER INFORMATION CONTACT: NOT-OD-17-101.html). Institute Special Emphasis Panel; SEP–8B: Karen Parker, Ph.D., Director, Sexual & Letters of Intent NCI Omnibus R03. Gender Minority Research Office Date: June 19, 2018. (SGMRO), 1 Center Drive, Building 1, A Letter of Intent (LOI) to submit a Time: 10:00 a.m. to 5:00 p.m. Room 257, Bethesda, MD 20892, nomination is required (nominees may Agenda: To review and evaluate grant klparker@mail.nih.gov, 301–451–2055. self-nominate and submit their own applications. LOIs). The LOI should be a 1-page, SUPPLEMENTARY INFORMATION: ‘‘Sexual Place: National Cancer Institute, Shady single-spaced Word or PDF document and gender minority’’ is an umbrella Grove, 9609 Medical Center Drive, Room and include: 7W238, Rockville, MD 20850 (Telephone term that encompasses lesbian, gay, bisexual, and transgender populations 1. Nominee’s name, title, affiliation, Conference Call). and date of terminal degree. Contact Person: Jeffrey E. DeClue, Ph.D., as well as those whose sexual orientation, gender identity and 2. eRA Commons ID. Scientific Review Officer, Research Programs expressions, or reproductive a. Before submitting the LOI, Review Branch, Division of Extramural Activities, National Cancer Institute, NIH development varies from traditional, researchers should confirm ESI status is 9609, Medical Center Drive, Room 7W238, societal, cultural, or physiological correctly marked in their eRA Commons Bethesda, MD 20892–9750, 240–276–6371, norms. (https://era.nih.gov/) profile. If the decluej@mail.nih.gov. The Sexual and Gender Minority status is incorrect, please contact the Research Office (SGMRO) coordinates NIH eRA Service Desk (https:// (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; sexual and gender minority (SGM)– grants.nih.gov/support/index.html) to 93.393, Cancer Cause and Prevention related research and activities by resolve the issue before submitting an daltland on DSKBBV9HB2PROD with NOTICES Research; 93.394, Cancer Detection and working directly with the NIH LOI. Diagnosis Research; 93.395, Cancer Institutes, Centers, and Offices. The 3. SGM research focus of nominee’s Treatment Research; 93.396, Cancer Biology Office was officially established in work. Research; 93.397, Cancer Centers Support; September 2015 within the NIH Attach the LOI (as a Word or PDF 93.398, Cancer Research Manpower; 93.399, Division of Program Coordination, document) to an email and send it to Cancer Control, National Institutes of Health, Planning, and Strategic Initiatives sgmhealthresearch@od.nih.gov with the HHS) (DPCPSI). subject line ‘‘2018 SGM Investigator VerDate Sep<11>2014 19:21 Apr 05, 2018 Jkt 244001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1

Federal Register / Vol. 83, No. 67 / Friday, April 6, 2018 / Notices 14871 Award Letter of Intent’’ no later than DEPARTMENT OF HEALTH AND circumstances in which active rescue is 11:59 p.m. on April 20, 2018. HUMAN SERVICES initiated, including the caller’s agreement to receive the intervention. Nominations Substance Abuse and Mental Health To capture differences across centers, Nomination packages may be Services Administration the form also collects information on submitted by the nominee or a counselors’ employment status and nominee’s mentor or colleague. Agency Information Collection hours worked/volunteered, level of Nomination packages must be a single Activities: Submission for OMB education, license status, training status, PDF file that includes: Review; Comment Request source of safety planning protocols, and 1. NIH Biosketch including a link Periodically, the Substance Abuse and responsibility for follow up. (URL) to the nominee’s My Bibliography Clearance is being requested for one Mental Health Services Administration in PubMed. activity to assess the knowledge, (SAMHSA) will publish a summary of a. If you do not have a My actions, and practices of counselors to information collection requests under Bibliography in PubMed, refer to these aid callers who are determined to be at OMB review, in compliance with the simple step-by-step instructions to save imminent risk for suicide and who may Paperwork Reduction Act (44 U.S.C. your citations in PubMed to a ‘‘My require active rescue. This evaluation Chapter 35). To request a copy of these Bibliography.’’ will allow researchers to examine and documents, call the SAMHSA Reports b. Use the URL that PubMed understand the actions taken by Clearance Officer on (240) 276–1243. counselors to aid imminent risk callers, automatically generates when you change your ‘‘My Bibliography’’ sharing Project: Networking Suicide Prevention the need for active rescue, the types of Hotlines—Evaluation of Imminent Risk interventions used, and, ultimately, setting to public. (OMB No. 0930–0333)—REVISION improve the delivery of crisis hotline 2. Letter of nomination (1,000 words services to imminent risk callers. A total or less) from a mentor or colleague The Substance Abuse and Mental of seven centers will participate in this familiar with the nominee’s work, Health Services Administration’s evaluation. Thus, SAMHSA is addressing the nominee’s innovative (SAMHSA), Center for Mental Health requesting OMB review and approval of contribution to the field of SGM health Services (CMHS) funds a National the Imminent Risk Form-Revised. research, crosscutting and collaborative Suicide Prevention Lifeline Network Crisis counselors at seven nature of that research, trajectory of (‘‘Lifeline’’), consisting of a toll-free participating centers will record career development, and leadership telephone number that routes calls from information discussed with imminent strengths. The strongest letters will anywhere in the United States to a risk callers on the Imminent Risk Form- demonstrate the lasting significance and network of local crisis centers. In turn, Revised, which does not require direct impact of the nominee’s work to date. the local centers link callers to local data collection from callers. As with 3. Two letters of endorsement from emergency, mental health, and social previously approved evaluations, callers other mentors or colleagues. Letters of service resources. This project is a will maintain anonymity. Participating endorsement may be less encompassing revision of the Evaluation of Imminent counselors will be asked to complete the than the letter of nomination, but Risk and builds on previously approved form for 100% of their imminent risk should address similar themes. data collection activities [Evaluation of calls. At centers with high call volumes, 4. A PDF of a key, peer-reviewed Networking Suicide Prevention Hotlines data collection may be limited to article published in the past 24-month Follow-Up Assessment (OMB No. 0930– designated shifts. This form requests period, which is first-authored by the 0274) and Call Monitoring of National information in 15 content areas, each nominee. If in press, please provide the Suicide Prevention Lifeline Form (OMB with multiple sub-items and response accepted paper and the letter of No. 0930–0275)]. The extension data options. Response options include acceptance from the journal. collection is an effort to advance the open-ended, yes/no, Likert-type ratings, After compiling all the above understanding of crisis hotline and multiple choice/check all that elements into a single PDF file, attach utilization and its impact. apply. The form also requests the PDF to an email, and send it to The overarching purpose of the demographic information on the caller, sgmhealthresearch@od.nih.gov with the proposed Evaluation of Imminent Risk the identification of the center and subject line header ‘‘2018 SGM data collection is to evaluate hotline counselor submitting the form, and the Investigator Award Nomination’’ no counselors’ management of imminent date of the call. Specifically, the form is later than 11:59 p.m. on May 18, 2018. risk callers and third party callers divided into the following sections: (1) concerned about persons at imminent Counselor information, (2) center Review and Selection Process risk, assess counselor adherence to the information, (3) call characteristics (e.g., • Stage 1: The SGMRO will assemble Lifeline Policies and Guidelines for line called, language spoken, a review panel composed of NIH staff Helping Callers at Imminent Risk of participation of third party), (4) suicidal with relevant expertise. This panel will Suicide, and identify the types of desire, (5) suicidal intent, (6) suicidal provide recommendations to the interventions implemented with capability, (7) buffers to suicide, (8) SGMRO Director and the DPCPSI imminent risk callers. Specifically, the interventions agreed to by caller or Director on awardees. Evaluation of Imminent Risk will collect implemented by counselor without • Stage 2: The SGMRO and DPCPSI data, using the Imminent Risk Form- caller’s consent, (9) whether imminent Directors will review the Revised, to inform the network’s risk was reduced enough such that recommendations and select the final knowledge of the extent to which active rescue was not needed, (10) daltland on DSKBBV9HB2PROD with NOTICES awardees. counselors are aware of and being interventions for third party callers guided by Lifeline’s imminent risk calling about a person at imminent risk, Dated: March 8, 2018. guidelines; counselors’ definitions of (11) whether supervisory consultation Lawrence A. Tabak, imminent risk; the rates of active rescue occurred during or after the call, (12) Deputy Director, National Institutes of Health. of imminent risk callers; the types of barriers to getting needed help to the [FR Doc. 2018–07066 Filed 4–5–18; 8:45 am] rescue and non-rescue interventions person at imminent risk, (13) steps BILLING CODE 4140–01–P used; barriers to intervention; and the taken to confirm whether emergency VerDate Sep<11>2014 19:21 Apr 05, 2018 Jkt 244001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1


Document Created: 2018-11-01 09:15:58
Document Modified: 2018-11-01 09:15:58
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice; call for Letters of Intent.
DatesNotices of intent to apply due April 20, 2018 and final nominations due May 18, 2018.
ContactKaren Parker, Ph.D., Director, Sexual & Gender Minority Research Office (SGMRO), 1 Center Drive, Building 1, Room 257, Bethesda, MD 20892, [email protected], 301-451-2055.
FR Citation83 FR 14870 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR